| USP订购编号 |
美国药典，USP分析标准品，英文名称，规格 |
CAS编号查询 |
UN编号对照 |
| USP-1269378 |
Febantel Related Compound B (15 mg) (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole) |
92114-71-1 |
|
| 2933998350 |
|
|
|
| USP-1269389 |
Felodipine (300 mg) |
72509-76-3 |
UN3077 |
| USP-1269390 |
Felodipine Related Compound A (15 mg) (3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) |
96382-71-7 |
|
| 2933399095 |
|
|
|
| USP-1269403 |
Fenbendazole (100 mg) |
43210-67-9 |
|
| 2933994600 |
|
|
|
| USP-1269414 |
Fenbendazole Related Compound A (30 mg) (Methyl (1H-benzimidazole-2-yl)carbamate) |
10605-21-7 |
UN3077 |
| USP-1269425 |
Fenbendazole Related Compound B (30 mg) (Methyl [5(6)-chlorobenzimidazole-2-yl]carbamate) |
20367-38-8 |
|
| 2933997500 |
|
|
|
| USP-1269436 |
Fenofibric Acid (250 mg) (2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid) |
42017-89-0 |
|
| 2918992090 |
|
|
|
| USP-1269447 |
Fenofibrate (200 mg) |
49562-28-9 |
|
| 2918992090 |
|
|
|
| USP-1269458 |
Fenoldopam Mesylate (200 mg) |
67227-57-0 |
|
| 2933995300 |
|
|
|
| USP-1269469 |
Fenoldopam Related Compound A (20 mg) (N-Methyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol hydrochloride) |
N/A |
|
| 2933997500 |
|
|
|
| USP-1269470 |
Fenoldopam Related Compound B (20 mg) (1-(4-Hydroxyphenyl)-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol methanesulfonate) |
N/A |
|
| 2933998350 |
|
|
|
| USP-1269505 |
Fenoprofen Calcium (500 mg) |
71720-56-4 |
|
| 2918992090 |
|
|
|
| USP-1269550 |
Fenoprofen Sodium (500 mg) |
66424-46-2 |
|
| 2918992090 |
|
|
|
| USP-1269607 |
Fenofibrate Related Compound A (25 mg) ((4-Chlorophenyl)(4-hydroxyphenyl)methanone) |
42019-78-3 |
|
| 2914710000 |
|
|
|
| USP-1269618 |
Fenofibrate Related Compound B (25 mg) (2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid) |
42017-89-0 |
|
| 2918992090 |
|
|
|
| USP-1269629 |
Fenofibrate Related Compound C (25 mg) (1-methylethyl 2-[[2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoyl]oxy]-2-methylpropanoate) |
217636-48-1 |
|
| 2918992090 |
|
|
|
| USP-1269924 |
Fentanyl Related Compound B (10 mg) (4-Anilinopiperidine) |
23056-29-3 |
|
| 2933399095 |
|
|
|
| USP-1269946 |
Fentanyl Related Compound D (10 mg) (N-Phenyl-1-(phenylmethyl)-4-piperidinamine) |
1155-56-2 |
|
| 2933399095 |
|
|
|
| USP-1270231 |
Trigonella Foenum-graecum Seed Dry Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1270311 |
Ferulic Acid (25 mg) ((E)-3-(4-hydroxy-3-methoxyphenyl)acrylic acid) |
537-98-4 |
|
| 2918992090 |
|
|
|
| USP-1270355 |
Ferrous Sulfate (2 x 1 g) |
7782-63-0 |
UN3077 |
| USP-1270363 |
Fexofenadine (200 mg) (2-(4-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid dihydrate) |
885946-90-7 |
|
| 2933399095 |
|
|
|
| USP-1270377 |
Fexofenadine Hydrochloride (200 mg) |
153439-40-8 |
|
| 2933399095 |
|
|
|
| USP-1270388 |
Fexofenadine Related Compound A (25 mg) (2-(4-{4-[4-(Hydroxydiphenylmethyl)piperidin-1-yl]butanoyl}phenyl)-2-methylpropanoic acid) |
76811-98-8 |
|
| 2933399095 |
|
|
|
| USP-1270399 |
Fexofenadine Related Compound B (25 mg) (2-(3-{1-Hydroxy-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butyl}phenyl)-2-methylpropanoic acid hydrochloride monohydrate) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1270402 |
Finasteride (200 mg) |
98319-26-7 |
|
| 2937290000 |
|
|
|
| USP-1270446 |
Fexofenadine Related Compound C (25 mg) ((+/-)-4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butyl]-isopropylbenzene hydrochloride) |
N/A |
|
| 2933399095 |
|
|
|
| USP-1270480 |
Fingolimod Hydrochloride (300 mg) |
162359-56-0 |
UN3077 |
| USP-1270526 |
Fingolimod System Suitability Mixture (40 mg) |
N/A |
UN3077 |
| USP-1270708 |
Flavoxate Hydrochloride (200 mg) |
3717-88-2 |
|
| 2934990005 |
|
|
|
| USP-1270719 |
Flavoxate Related Compound A (25 mg) (3-methylflavone-8-carboxylic acid) |
3468/1/7 |
|
| 2932996560 |
|
|
|
| USP-1270720 |
Flavoxate Related Compound B (20 mg) (Methyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate) |
90101-87-4 |
|
| 2932996560 |
|
|
|
| USP-1283313 |
Foscarnet Related Compound B (10 mg) (disodium (ethoxyoxidophosphanyl)formate) |
N/A |
|
| 2931490000 |
|
|
|
| USP-1012633 |
Albuterol Sulfate (200 mg) |
51022-70-9 |
|
| 2922504500 |
|
|
|
| USP-1012644 |
Albuterol Related Compound A (25 mg) (4-[2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl]-2-methylphenol sulfate) |
2044704-57-4 |
|
| 2922504500 |
|
|
|
| USP-1012655 |
Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone) |
156547-62-5 |
|
| 2922504500 |
|
|
|
| USP-1012689 |
Albuterol Related Compound E (10 mg) (2,2′-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate) |
N/A |
|
| 2922504500 |
|
|
|
| USP-1012746 |
Alclometasone Dipropionate Related Compound A (20 mg) (11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17,21-dipropionate) |
N/A |
|
| 2937290000 |
|
|
|
| USP-1012757 |
Alclometasone Dipropionate (300 mg) |
66734-13-2 |
|
| 2937220000 |
|
|
|
| USP-1012780 |
Alendronate Sodium (200 mg) |
121268-17-5 |
|
| 2931909000 |
|
|
|
| USP-1012799 |
Aleuritic Acid (50 mg) |
533-87-9 |
|
| 2918195000 |
|
|
|
| USP-1012848 |
Alitame (250 mg) |
99016-42-9 hydrated |
|
| 2934990005 |
|
|
|
| USP-1012859 |
Alitame – Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alanimamide) |
80875-07-6 |
|
| 2934990005 |
|
|
|
| USP-1012871 |
Alfuzosin System Suitability Mixture A (25 mg) (Alfuzosin Hydrochloride containing Impurity A, Impurity D, and Impurity E) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1012917 |
Alfuzosin Hydrochloride (150 mg) |
81403-68-1 |
|
| 2934990005 |
|
|
|
| USP-1012928 |
Alfuzosin System Suitability Mixture (15 mg) |
N/A |
|
| 3822190000 |
|
|
|
| USP-1012939 |
Allantoin (200 mg) |
97-59-6 |
|
| 2933210000 |
|
|
|
| USP-1012941 |
Alginic Acid (100 mg) |
9005-32-7 |
|
| 3913100000 |
|
|
|
| USP-1012950 |
Alliin (25 mg) |
556-27-4 |
|
| 2930904990 |
|
|
|
| USP-1013002 |
Allopurinol (250 mg) |
315-30-0 |
UN3077 |
| USP-1013013 |
Allopurinol Related Compound B (25 mg) (5-(formylamino)-1H-pyrazole-4-carboxamide) |
22407-20-1 |
|
| 2933199050 |
|
|
|
| USP-1013024 |
Allopurinol Related Compound A (25 mg) (3-Amino-4-carboxamidopyrazole Hemisulfate) |
27511-79-1 |
|
| 2933199050 |
|
|
|
| USP-1013035 |
Allopurinol Related Compound C (25 mg) (5-(4H-1,2,4-triazol-4-yl)-1H-pyrazole-4-carboxamide) |
1346604-13-4 |
|
| 2933199050 |
|
|
|
| USP-1013046 |
Allopurinol Related Compound D (35 mg) (Ethyl 5-amino-1H-pyrazole-4-carboxylate) |
6994-25-8 |
UN3077 |
| USP-1013057 |
S-Allyl-L-Cysteine (25 mg) |
21593-77-1 |
|
| 2930904990 |
|
|
|
| USP-1013068 |
Allopurinol Related Compound E (25 mg) (ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate) |
31055-19-3 |
|
| 2933199050 |
|
|
|
| USP-1013079 |
Allopurinol Related Compound F (25 mg) (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate) |
321571-07-7 |
|
| 2933199050 |
|
|
|
| USP-1013115 |
Allulose (200 mg) |
551-68-8 |
|
| 2940006000 |
|
|
|
| USP-1013512 |
Almotriptan Malate (200 mg) |
181183-52-8 |
|
| 2935904000 |
|
|
|
| USP-1013523 |
Almotriptan Related Compound A (20 mg) ({3-[2-(Dimethylamino)ethyl]-5-[(pyrrolidine-1-yl)sulfonylmethyl]-1H-indol-1-yl}methanol) |
1018676-02-2 |
|
| 2935909550 |
|
|
|
| USP-1013534 |
Almotriptan System Suitability (20 mg) (Mixture of Almotriptan Malate and Almotriptan Monomethyl Analog) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1013545 |
Almotriptan Related Compound B (15 mg) (2-{5-[(pyrrolidin-1-ylsulfonyl)methyl]-1H-indol-3-yl}ethanamine hemifumarate) |
1246860-65-0 |
|
| 2933997500 |
|
|
|
| USP-1457797 |
Nebivolol Stereoisomer Mixture (15 mg) |
N/A |
UN3077 |
| USP-1457833 |
Nebivolol Hydrochloride (150 mg) |
152520-56-4 |
UN3077 |
| USP-1457855 |
Nebivolol Related Compound A (30 mg) (See USP Certificate for full Chemical Name) |
N/A |
|
| 2932996560 |
|
|
|
| USP-1457866 |
Nebivolol Related Compound B (30 mg) (See USP Certificate for full Chemical Name) |
N/A |
|
| 2932996560 |
|
|
|
| USP-1457877 |
Nebivolol Related Compound C (100 mg) (需冷链运输) ((RS)-6-Fluoro-2-[(RS)-oxiran-2-yl]chroman) |
876514-31-7 |
UN3077 |
| USP-1457888 |
Nebivolol Related Compound D (100 mg) ((RS)-6-Fluoro-2-[(SR)-oxiran-2-yl]chroman) |
793669-26-8 |
UN3077 |
| USP-1457899 |
Nebivolol Related Compound E (30 mg) (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride) |
N/A |
|
| 2932996560 |
|
|
|
| USP-1457902 |
Nefazodone Hydrochloride (200 mg) |
82752-99-6 |
|
| 2933595960 |
|
|
|
| USP-1457913 |
Nefazodone Related Compound A (25 mg) (1-(3-chlorophenyl)-4-(3-chloropropyl)-piperazine hydrochloride) |
57059-62-8 |
|
| 2933599550 |
|
|
|
| USP-1457924 |
Nefazodone Related Compound B (25 mg) (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride) |
N/A |
|
| 2933599550 |
|
|
|
| USP-1458019 |
Neomycin B (150 mg) |
28002-70-2 |
|
| 2941906000 |
|
|
|
| USP-1458020 |
Neomycin A (2.5 mg) |
3947-65-7 (free base) |
|
| 2940006000 |
|
|
|
| USP-1458031 |
Neomycin Sulfate System Suitability Mixture (100 mg) |
N/A |
|
| 2941901010 |
|
|
|
| USP-1458042 |
Neohesperidin (30 mg) ((S)-5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranoside) |
13241-33-3 |
|
| 2938900000 |
|
|
|
| USP-1458064 |
Neodiosmin (30 mg) (5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-4H-chromen-7-yl 2-O-(alpha-L-rhamnopyranosyl)-beta-Dglucopyranoside) |
38665-01-9 |
|
| 2938900000 |
|
|
|
| USP-1478833 |
Orlistat Related Compound C (25 mg) (Triphenylphosphine oxide) |
791-28-6 |
|
| 2931490000 |
|
|
|
| USP-1478855 |
Orlistat Related Compound E (10 mg) (N-Formyl (S)-isoleucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester) |
1072902-75-0 |
|
| 2932206000 |
|
|
|
| USP-1479009 |
Orphenadrine Citrate (200 mg) |
4682-36-4 |
UN2811 |
| USP-1479010 |
Orphenadrine Related Compound A (50 mg) ((RS)-N,N-dimethyl-2-[(3-methylphenyl)-phenylmethoxy]ethanamine citrate) (AS) |
N/A |
|
| 2922199695 |
|
|
|
| USP-1479020 |
Orphenadrine Related Compound B (20 mg) (N-Ethyl-N,N-dimethyl-2-[phenyl(o-tolyl)methoxy]ethanaminium chloride; also known as N-Ethyl-N,N-dimethyl-2-[phenyl(2-tolyl)methoxy]ethanaminium chloride) |
93940-17-1 |
|
| 2923900100 |
|
|
|
| USP-1479031 |
Orphenadrine Related Compound C (20 mg) (N-methyl-2-[phenyl(o-tolyl)methoxy]ethanamine hydrochloride) |
10488-36-5 |
|
| 2922190900 |
|
|
|
| USP-1485114 |
Oxybutynin Related Compound A (100 mg) (Phenylcyclohexylglycolic Acid) |
4335-77-7 |
|
| 2918195000 |
|
|
|
| USP-1485125 |
Oxybutynin Related Compound B (20 mg) (Cyclohexyl Mandelic Acid Methyl Ester) |
10399-13-0 |
|
| 2918195000 |
|
|
|
| USP-1485136 |
Oxybutynin Related Compound C (20 mg) (4-(ethylmethylamino)but-2-ynyl(+/-)-2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride) |
N/A |
|
| 2922199695 |
|
|
|
| USP-1486004 |
Oxymetazoline Hydrochloride (200 mg) |
2315/2/8 |
UN2811 |
| USP-1486015 |
Oxymetazoline Related Compound A (15 mg) (N-(2-Aminoethyl)-2-[4-(tert-butyl)-3-hydroxy-2,6-dimethylphenyl]acetamide hydrochloride) |
1391053-50-1 |
|
| 2924296000 |
|
|
|
| USP-1487029 |
Oxymetholone Related Compound B (25 mg) (17Beta-Hydroxy-1-hydroxymethylene-17alpha-methyl-5alpha-androstan-3-one) |
N/A |
|
| 2914409000 |
|
|
|
| USP-1490103 |
Oxyquinoline Sulfate (200 mg) |
134-31-6 |
|
| 2933492250 |
|
|
|
| USP-1605045 |
Roflumilast Related Compound C (50 mg) (3,5-Dichloropyridin-4-amine) |
22889-78-7 |
|
| 2933399095 |
|
|
|
| USP-1605056 |
Roflumilast Related Compound D (50 mg) (3-(Cyclopropylmethoxy)-4-(difluoromethoxy)benzoic acid) |
162401-62-9 |
|
| 2918992090 |
|
|
|
| USP-1605067 |
Roflumilast Related Compound E (30 mg) (N-(3-Bromo-5-chloropyridin-4-yl)-3-(cyclopropylmethoxy)-4-(difluoromethoxy)benzamide) |
NA |
|
| 2933399095 |
|
|
|
| USP-1605205 |
Ropinirole Hydrochloride (200 mg) |
91374-20-8 |
|
| 2933790002 |
|
|
|
| USP-1605216 |
Ropinirole Related Compound A (50 mg) (4-(2-hydroxyethyl)indolin-2-one) |
139122-19-3 |
|
| 2933790002 |
|
|
|
| USP-1605227 |
Ropinirole Related Compound B (50 mg) (4-[2-(Dipropylamino)ethyl]indoline-2,3-dione hydrochloride) |
221264-21-7 |
|
| 2933790002 |
|
|
|
| USP-1605497 |
Ropivacaine (200 mg) |
84057-95-4 |
|
| 2933399095 |
|
|
|
| USP-1614909 |
Sodium Tartrate Dihydrate (500 mg/vial; 4 vials) |
6106-24-7 |
|
| 2918130000 |
|
|
|
| USP-1615107 |
Sodium Thiosulfate (1 g) |
10102-17-7 |
|
| 2832300000 |
|
|
|
| USP-1615138 |
Sodium Trifluoroacetate (500 mg) |
2923-18-4 |
|
| 2915900000 |
|
|
|
| USP-1615300 |
Solifenacin Succinate (100 mg) |
242478-38-2 |
|
| 2933497050 |
|
|
|
| USP-1615311 |
Solifenacin Identification Mixture A (15 mg) |
N/A |
|
| 2933497050 |
|
|
|
| USP-1615322 |
Solifenacin Identification Mixture B (20 mg) |
N/A |
|
| 2933497050 |
|
|
|
| USP-1615810 |
Sophora Japonica Flower Dry Extract (500 mg) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1615876 |
Sorafenib Tosylate (200 mg) |
475207-59-1 |
|
| 2933399095 |
|
|
|
| USP-1615887 |
Sorafenib Related Compound H (25 mg) (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide) |
1431697-81-2 |
|
| 2933399095 |
|
|
|
| USP-1615956 |
Sorbic Acid (1 g) |
110-44-1 |
|
| 2916192000 |
|
|
|
| USP-1616008 |
1,4-Sorbitan (300 mg) |
27299-12-3 |
|
| 2932190002 |
|
|
|
| USP-1617000 |
Sorbitol (125 mg) |
50-70-4 |
|
| 2905440000 |
|
|
|
| USP-1617408 |
Sotalol Hydrochloride (300 mg) |
959-24-0 |
|
| 2935904000 |
|
|
|
| USP-1617419 |
Sotalol Related Compound A (50 mg) (N-[4-[[(1-Methylethyl)amino]acetyl]phenyl]methanesulfonamide monohydrochloride) |
N/A |
|
| 2935909550 |
|
|
|
| USP-1617420 |
Sotalol Related Compound B (50 mg) (N-(4-Formylphenyl)methanesulfonamide) |
83922-54-7 |
|
| 2935909550 |
|
|
|
| USP-1193006 |
Diethylcarbamazine Citrate (200 mg) |
1642-54-2 |
UN2811 |
| USP-1193356 |
Iscotrizinol (200 mg) |
154702-15-5 |
|
| 2933690000 |
|
|
|
| USP-1234103 |
Efavirenz (200 mg) |
154598-52-4 |
UN3077 |
| USP-1234114 |
Efavirenz Racemic (20 mg) (6-Chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) |
177530-93-7 |
|
| 2934990005 |
|
|
|
| USP-1234125 |
Efavirenz Related Compound A (20 mg) ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol) |
209414-27-7 |
|
| 2922199695 |
|
|
|
| USP-1234136 |
Efavirenz Related Compound C (20 mg) (6-chloro-2-cyclopropyl-4-(trifluoromethyl)quinoline) |
391860-73-4 |
|
| 2933497050 |
|
|
|
| USP-1234147 |
Efavirenz Related Compound B (10 mg) ((S,E)-6-Chloro-4-(2-Cyclopropylvinyl)-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one) |
440124-96-9 |
|
| 2934990005 |
|
|
|
| USP-1234249 |
Eflornithine Hydrochloride (150 mg) |
96020-91-6 |
|
| 2922498050 |
|
|
|
| USP-1234260 |
Egeline (10 mg) |
456-12-2 |
|
| 2924296000 |
|
|
|
| USP-1234340 |
European Elder Berry Dry Extract (1 g) |
N/A |
|
| 1302190200 |
|
|
|
| USP-1234453 |
Eletriptan Hydrobromide (200 mg) (3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole monohydrobromide monohydrate) |
273211-28-2 |
|
| 2933995500 |
|
|
|
| USP-1234475 |
Eletriptan Related Compound B (20 mg) ((R)-5-Bromo-3-[(1-methylpyrrolidin-2-yl)methyl]-1H-indole) |
143322-57-0 |
UN3077 |
| USP-1234522 |
Eletriptan S-Enantiomer (20 mg) ((S)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethyl]-1H-indole, monohydrobromide) |
N/A |
|
| 2933995500 |
|
|
|
| USP-1234668 |
Eleutheroside B (15 mg) (Syringin) |
118-34-3 |
|
| 2938900000 |
|
|
|
| USP-1234704 |
Powdered Eleuthero Extract (1.5 g) |
84696-12-5 |
|
| 1302190200 |
|
|
|
| USP-1234806 |
Emedastine Difumarate (100 mg) |
87233-62-3 |
|
| 2933992600 |
|
|
|
| USP-1235004 |
Emetine Hydrochloride (300 mg) |
7083-71-8 |
UN1544 |
| USP-1235059 |
Emodin (30 mg) (1,3,8-trihydroxy-6-methylanthracene-9,10-dione) |
518-82-1 |
|
| 2914692100 |
|
|
|
